本文關(guān)鍵詞：雙參鎮(zhèn)咳湯治療感染后咳嗽（風(fēng)咳證）的臨床與實(shí)驗(yàn)研究　出處：《南京中醫(yī)藥大學(xué)》2017年碩士論文　論文類型：學(xué)位論文

  更多相關(guān)文章： 感染后咳嗽 風(fēng)咳證 雙參鎮(zhèn)咳湯 動物試驗(yàn) 臨床試驗(yàn)

【摘要】：目的.：評價導(dǎo)師經(jīng)驗(yàn)方雙參鎮(zhèn)咳湯治療感染后咳嗽(風(fēng)咳證)的臨床與實(shí)驗(yàn)療效。方法：1.文獻(xiàn)研究:通過對近十年來(2006年～2016年)有關(guān)感染后咳嗽和風(fēng)咳證的文章進(jìn)行閱讀和分析,歸納其現(xiàn)代醫(yī)學(xué)病因、發(fā)病機(jī)制、治療及轉(zhuǎn)歸、風(fēng)咳證的溯源、理法方藥、臨床治療等,深入分析感染后咳嗽與風(fēng)咳證的聯(lián)系。綜述目前中西醫(yī)關(guān)于感染后咳嗽認(rèn)識及治療存在的不足。2.動物試驗(yàn):將氨水誘發(fā)咳嗽的小鼠模型110只,隨機(jī)分為模型對照組、蘇黃止咳膠囊中藥對照組、開瑞坦西藥對照組、雙參湯組處方1的4個劑量組、經(jīng)導(dǎo)師加減的雙參湯處方2的4個劑量組(分別相當(dāng)于臨床劑量的2倍、1倍、1/2倍、1/4倍)每組各10只,對小鼠第一聲咳嗽的時間(潛伏期),3分鐘內(nèi)咳嗽的次數(shù)進(jìn)行記錄,進(jìn)行統(tǒng)計(jì)學(xué)分析。將卵蛋白誘發(fā)過敏性支氣管痙攣的豚鼠模型120只,隨機(jī)分為空白對照組、模型對照組、蘇黃止咳膠囊中藥對照組、開瑞坦西藥對照組、雙參湯組處方1的4個劑量組、經(jīng)導(dǎo)師加減的雙參湯處方2的4個劑量組(分別相當(dāng)于臨床劑量的2倍、1倍、1/2倍、1/4倍)每組各10只,對豚鼠自停止噴霧到出現(xiàn)喘息性抽搐的時間(潛伏期),及發(fā)生跌倒休克的動物數(shù)進(jìn)行記錄,結(jié)果進(jìn)行統(tǒng)計(jì)學(xué)處理3.臨床試驗(yàn):將符合感染后咳嗽風(fēng)咳證納入標(biāo)準(zhǔn)的60名患者,按簡單隨機(jī)分組法分兩組:試驗(yàn)組30例,予導(dǎo)師經(jīng)驗(yàn)方"雙參鎮(zhèn)咳湯" 口服;對照組30例,予"惠菲寧(美敏偽麻溶液)"治療。療程均為兩周。觀察兩組患者治療前后的中醫(yī)證候積分情況,采用SPSS 19.0進(jìn)行統(tǒng)計(jì)分析,比較兩組療效差異。結(jié)果:1.文獻(xiàn)歸納總結(jié)出了感染后咳嗽風(fēng)咳證中西醫(yī)醫(yī)學(xué)的認(rèn)識,但仍存在以下不足:現(xiàn)代醫(yī)學(xué)方面:(1)國際上尚未有公認(rèn)的診斷標(biāo)準(zhǔn)。(2)缺乏具備診斷意義的理化指標(biāo)。(3)以對癥治療為主,副作用明顯。(4)沒有療效評價的統(tǒng)一指標(biāo)。中醫(yī)學(xué)方面:(1)在本病的歸屬上尚無一致認(rèn)識。(2)缺少統(tǒng)一的中醫(yī)證候?qū)W觀察指標(biāo)。(3)無一致的治療方案(4)多數(shù)中西醫(yī)結(jié)合治療還不很成熟,多為簡單機(jī)械地中藥加西藥聯(lián)合治療。2.通過動物試驗(yàn),處方1和處方2在所試劑量范圍內(nèi)對氨水引發(fā)小鼠咳嗽模型及卵白蛋白引發(fā)豚鼠支氣管痙攣模型有減少咳嗽次數(shù)、延長咳嗽潛伏期的作用。對氨水引發(fā)小鼠咳嗽模型處方2作用優(yōu)于處方1,且處方2等倍劑量組與模型組相比,具有顯著統(tǒng)計(jì)學(xué)差異(P0.05);對卵白蛋白引發(fā)豚鼠支氣管痙攣模型處方1稍優(yōu)于處方2,但與模型組相比,無顯著統(tǒng)計(jì)學(xué)差異。兩個處方的最佳藥效劑量基本均為臨床等倍劑量。3.臨床試驗(yàn)結(jié)果:1)兩組治療后主癥咳嗽,次癥咽癢、氣急及中醫(yī)證候總積分均較治療前改善(P0.05)。2)與對照組相比,治療2周后,試驗(yàn)組在咳嗽,咽癢及中醫(yī)證候總積分上明顯好轉(zhuǎn)(P0.05)。3)兩組的臨床療效上,治療2周后試驗(yàn)組控顯率為70%,總有效率為100%;對照組控顯率33.3%,總有效率為96.7%,兩組的總有效率相比具有顯著統(tǒng)計(jì)學(xué)差異,且試驗(yàn)組的療效優(yōu)于對照組(P0.05)。結(jié)論:導(dǎo)師經(jīng)驗(yàn)方雙參鎮(zhèn)咳湯在動物試驗(yàn)和臨床觀察中都對感染后咳嗽有較好的鎮(zhèn)咳效果。
[Abstract]:Objective: To evaluate the tutor experience. Shuangshen Decoction in the treatment of cough cough after infection (wind cough syndrome) clinical and experimental efficacy. Methods: 1. literature research: Based on the recent ten years (2006 ~ 2016) related cough after infection and wind cough syndrome articles were read and analyzed, summed up the modern medical pathogenesis the pathogenesis, treatment, and outcome of the wind cough syndrome of prescription, clinical treatment, in-depth analysis of cough after infection with the wind cough syndrome linked. The review of current traditional Chinese and Western Medicine on the understanding and treatment of cough after infection problems of.2. animal experiment: the ammonia induced cough in mice model 110, random divided into model control group, Chinese medicine control group Suhuangzhike capsule clarityne, western medicine group, 4 dose groups of Shuangshen Decoction group of 1 prescriptions, 4 dose groups after the prescription of Shuangshen Decoction and mentor 2 (respectively, equivalent to clinical dose 2 times, 1 times, 1/2 times, 1/4 times) each 10 rats in each group of mice, the first cough time (incubation period), the number of 3 minutes of cough were recorded for statistical analysis. The ovalbumin induced allergic bronchospasm guinea pig model of 120 rabbits were randomly divided into control group, model control group, Suhuang capsule of traditional Chinese medicine group, western medicine clarityne the control group, 4 dose groups of Shuangshen Decoction group of 1 prescriptions, 4 dose groups after the prescription of Shuangshen Decoction and mentor 2 (respectively, equivalent to clinical dose 2 times, 1 times, 1/2 times, 1/4 times) with 10 rats in each group of guinea pigs, self stop spraying into asthmatic convulsions time (latency), and the number of animal falls with shock records, the results were statistically analyzed in 3. clinical trials: 60 patients with post infectious cough wind cough syndrome criteria, according to a simple random grouping method is divided into two groups: 30 cases in the experimental group, to guide teachers "experience of Shuangshen oral antitussive Decoction"; The control group of 30 cases, treated with "Hui Feining (Pseudoephedrine Hydrochloride Chlorphenamine Maleate and Dextromethorphan Hydrobromide Solution)". The treatment lasted for two weeks. To observe the TCM Syndromes of two groups of patients before and after treatment, SPSS 19 was used for statistical analysis, comparison of efficacy between the two groups. Results: 1. the literature summarized the understanding of post infection cough wind cough syndrome of traditional Chinese medicine and Western medicine medicine, but there are still the following problems: modern medicine: (1) International has not yet accepted diagnostic criteria. (2) the lack of physical and chemical indicators have diagnostic significance. (3) for symptomatic treatment, obvious side effects. (4) there is no unified index in the evaluation of curative effect of traditional Chinese medicine: (. 1) there is no unanimity in the disease attributable to. (2) lack of unified science of TCM syndromes observed. (3) no consistent treatment (4) the majority of integrated traditional Chinese and Western medicine treatment is not very mature, multi joint treatment of.2. through animal experiments for the simple machinery of traditional Chinese medicine with western medicine, prescription 1 and prescription 2 In the range of reagent amount of ammonia caused mice cough model and ovalbumin have decrease the frequency of cough in guinea pig model induced bronchospasm, extend the cough incubation period of cough induced by ammonia. The effect is better than that of model 2 prescription prescription 1 and 2 times, compared with the prescription dose group and the model group, the difference was statistically significant (P0.05) lead to ovalbumin; guinea pig bronchial spasm model is slightly better than the 1 Prescription prescription 2, but compared with the model group, there was no statistically significant difference. The best dose of two prescriptions were the basic test results to clinical doses of.3. clinical trial: 1) the main symptoms of cough in two groups after treatment, secondary symptoms of itchy throat, total score shortness of breath and TCM syndromes were better than those before treatment (P0.05).2) compared with the control group, after 2 weeks of treatment, the experimental group in cough, pharyngeal itching and total score of Chinese medicine symptom significantly improved (P0.05).3) the clinical curative effect of two groups, 2 weeks of treatment The experimental group after the control rate was 70%, the total effective rate was 100%; the control group control rate was 33.3%, the total effective rate was 96.7%, the total efficiency of the two groups compared to the difference was statistically significant, and the efficacy of the experimental group than the control group (P0.05). Conclusion: the tutor experience of Shuangshen Decoction in the animal experiment of cough and the clinical observation of cough after infection has antitussive effect better.

【學(xué)位授予單位】：南京中醫(yī)藥大學(xué)
【學(xué)位級別】：碩士
【學(xué)位授予年份】：2017
【分類號】：R256.11

【參考文獻(xiàn)】

相關(guān)期刊論文 前10條

1 張弘;葉姝均;沈淑華;林友寶;王坤根;;王坤根治療感染后咳嗽的經(jīng)驗(yàn)[J];中華中醫(yī)藥雜志;2016年07期

2 姜燕;劉昊;毛兵;;感染后咳嗽的中醫(yī)證型分布規(guī)律[J];長春中醫(yī)藥大學(xué)學(xué)報;2016年03期

3 何雪梅;盧育明;;感染后咳嗽氣道神經(jīng)源性炎癥水平與肺功能相關(guān)性研究[J];中國醫(yī)學(xué)創(chuàng)新;2014年19期

4 王彬輝;章文紅;張曉芬;夏修遠(yuǎn);洪偉勇;胡利明;;苦杏仁苷提取工藝及藥理作用研究新進(jìn)展[J];中華中醫(yī)藥學(xué)刊;2014年02期

5 王文;朱佳;;宣肺止嗽方治療感染后咳嗽臨床療效觀察[J];遼寧中醫(yī)藥大學(xué)學(xué)報;2014年02期

6 張瑜;武斌;許建衛(wèi);;黃芩藥理作用的研究進(jìn)展[J];醫(yī)學(xué)綜述;2013年06期

7 唐斌擎;張?zhí)灬?黃海茵;石克華;王麗新;喻曉;劉芳;方泓;吳銀根;;基于因子分析法探索感冒后咳嗽中醫(yī)證候分布規(guī)律[J];中華中醫(yī)藥學(xué)刊;2012年05期

8 董成梅;楊麗川;鄒澄;趙沛基;蒲洪;張瀅;;巖白菜素的研究進(jìn)展[J];昆明醫(yī)學(xué)院學(xué)報;2012年01期

9 楊靜;譚國平;;上呼吸道感染后慢性咳嗽患者呼吸功能測定及分析[J];實(shí)用醫(yī)學(xué)雜志;2010年23期

10 吳雪榮;;麻黃藥理作用研究進(jìn)展[J];中國中醫(yī)藥現(xiàn)代遠(yuǎn)程教育;2010年05期

，

本文編號：1439338